Skip to content Skip to footer
Legion
Legion
Close

Tesamorelin

Products sold by Legion Peptides are intended for laboratory research and in vitro studies only. These products are not intended for use in the diagnosis, treatment, cure, or prevention of any disease and have not been evaluated by the FDA. By purchasing, you confirm that these products will be used solely for research purposes and in compliance with all applicable laws and regulations.

Tesamorelin
Tesamorelin - Image 2
Tesamorelin - Image 3

Tesamorelin

Price range: $28.50 through $43.99

New

Tesamorelin is a synthetic GHRH analog that stimulates the pituitary to release endogenous Growth Hormone (GH), raising IGF-1 levels. Due to its long half-life, it is key for research into fat metabolism, muscle preservation, and endocrine modulation.

  • Peptides will arrive in a lyophilized (powder) form for maximum stability
Add to WishlistRemove from Wishlist
Add to Wishlist

Product Summary

NAD+ (Nicotinamide Adenine Dinucleotide, oxidized form) is a central coenzyme involved in cellular redox reactions and metabolic pathway regulation. It plays a foundational role in mitochondrial function research, oxidative phosphorylation models, and cellular energy transfer systems.

NAD+ functions as an electron carrier in numerous biochemical reactions and is widely studied in laboratory settings for its role in:

  • Cellular respiration pathways
  • Redox balance regulation
  • Mitochondrial metabolic processes
  • Enzyme-dependent signaling cascades
  • NAD-dependent deacetylase research models

As a biochemical cofactor, NAD+ is integral to fundamental metabolic research frameworks across cellular biology, molecular signaling, and enzymatic pathway studies.

Product Details:

– Form: Lyophilized NAD+ (oxidized form)
 – Purity: ≥99% (analytically verified)
 – Molecular Classification: Coenzyme
 – Certificate of Analysis (COA): Available upon request
 – Intended Use: Laboratory research only

NAD+ functions as a critical redox cofactor within cellular metabolic systems.

Redox Role

NAD+ participates in oxidation-reduction reactions by accepting electrons and becoming NADH. This electron transfer function is essential in:

  • Glycolysis research
  • Citric acid cycle modeling
  • Oxidative phosphorylation studies
Enzyme Interaction

NAD+ serves as a substrate for several enzyme classes including:

  • Sirtuins (NAD-dependent deacetylases)
  • PARPs (Poly ADP-ribose polymerases)
  • CD38 and related enzymatic pathways

These enzyme systems are widely investigated in cellular signaling and gene expression research.

Cellular Metabolic Integration

NAD+ supports research into:

  • Mitochondrial pathway modeling
  • Energy metabolism frameworks
  • Redox homeostasis systems
  • DNA repair pathway investigation
  • Intracellular signaling cascade analysis

All research use must adhere to institutional and regulatory guidelines.

NAD+ is utilized in laboratory environments for:

  • Mitochondrial function research
  • Redox balance studies
  • Enzyme activity modeling
  • NAD-dependent signaling research
  • Cellular metabolism pathway analysis
  • Biochemical reaction system investigation

It is commonly used in controlled in vitro biochemical assays and metabolic pathway experiments.

NAD+ is composed of:

  • Two nucleotides joined via phosphate groups
  • An adenine base
  • A nicotinamide moiety

Its oxidized structure enables electron acceptance during metabolic reactions, distinguishing it from its reduced form (NADH).

This structural framework makes it a central molecule in biochemical energy-transfer research.

Each batch of NAD+ undergoes analytical verification including:

  • High-Performance Liquid Chromatography (HPLC) purity testing
  • Identity confirmation analysis
  • Batch-level traceability documentation
  • Controlled lyophilization standards
  • Sterile sealed packaging

Certificates of Analysis are available upon request.

NAD+ is supplied as a sterile lyophilized powder.

Storage Guidelines:

  • Store refrigerated at 2–8°C
  • Protect from light exposure
  • Minimize moisture exposure
  • Avoid repeated freeze-thaw cycles
  • Follow proper laboratory handling protocols

The compound is supplied dry and is not pre-reconstituted.

This product is intended strictly for laboratory research purposes only.

It is not intended for human consumption, veterinary use, therapeutic application, or diagnostic use.

By purchasing this product, the buyer affirms compliance with all applicable laws and research regulations.

🧬 NAD+ — Frequently Asked Questions (FAQ)

NAD+ (Nicotinamide Adenine Dinucleotide) is a naturally occurring coenzyme involved in cellular redox reactions and metabolic pathway research.

It is used in laboratory settings to study mitochondrial function, redox balance, enzyme activity, and metabolic signaling pathways.

No. NAD+ is a coenzyme and not a peptide compound.

It is supplied as a sterile lyophilized powder for laboratory research use.

No. NAD+ is strictly intended for laboratory research purposes only.

Each batch is analytically verified to ≥99% purity. COA documentation is available upon request.

Store refrigerated at 2–8°C, protected from light and moisture, and handled using proper laboratory procedures.

Combination research must comply with institutional guidelines and regulatory standards.

COA documentation may be requested through our support team by referencing your order details.

Product Summary

The BPC-157 / TB-500 “Wolverine” Blend is a dual-component lyophilized peptide formulation designed for laboratory research investigating cellular signaling, cytoskeletal dynamics, extracellular matrix interactions, and multi-peptide pathway coordination.

This formulation combines two widely studied peptides with distinct but potentially complementary research profiles:

  • BPC-157 — a synthetic peptide derived from a gastric protein fragment, commonly studied in cytoprotective signaling and nitric-oxide–associated pathways
  • TB-500 — a synthetic fragment of thymosin beta-4, investigated for its interaction with actin-binding proteins and cellular migration models

By integrating these peptides into a single controlled formulation, the Wolverine blend provides a structured platform for evaluating overlapping signaling cascades and coordinated cellular response frameworks in vitro and in vivo research models.

Researchers use dual-peptide systems like this to examine how different molecular pathways may interact within complex biological systems, rather than studying isolated compounds independently.

Product Details

  • Form: Lyophilized multi-peptide blend
  • Composition: BPC-157 + TB-500
  • Purity: ≥99% (component-level analytical verification)
  • Manufacturing: Controlled production standards
  • COA: Available upon request
  • Intended Use: Laboratory research only

The Wolverine blend combines two peptides that interact with distinct yet potentially complementary biological signaling systems.

BPC-157

BPC-157 is investigated in laboratory models for its interaction with:

  • Nitric oxide signaling pathways
  • Cytoprotective cellular response mechanisms
  • Angiogenic signaling models
  • Cellular communication frameworks

Research involving BPC-157 often focuses on how cells respond to environmental stressors and how signaling pathways regulate cellular integrity.

TB-500 (Thymosin Beta-4 Fragment)

TB-500 is a synthetic fragment of thymosin beta-4 and is studied in relation to:

  • Actin-binding protein regulation
  • Cytoskeletal organization
  • Cellular migration models
  • Tissue-level structural signaling frameworks

Its interaction with actin dynamics makes it relevant in research involving cellular movement and structural protein systems.

Integrated Dual-Peptide Research Model

When combined, BPC-157 and TB-500 allow researchers to investigate:

  • Multi-pathway cellular signaling interaction
  • Cytoskeletal and extracellular matrix coordination
  • Cellular response and structural adaptation models
  • Peptide synergy and combinatory pathway analysis

This dual-peptide system supports experimental designs that evaluate complex biological interactions across multiple signaling networks.

The Wolverine blend is utilized in laboratory environments for research into:

  • Cellular signaling cascade modeling
  • Cytoskeletal protein interaction studies
  • Extracellular matrix pathway research
  • Multi-peptide interaction analysis
  • Cellular migration and structural pathway investigation
  • Integrated biological response frameworks

Researchers are responsible for experimental design and compliance with all applicable regulations.

Researchers may select the Wolverine blend for:

  • Multi-peptide synergy investigation
  • Consolidated formulation for streamlined experimental design
  • Reduced variability compared to separate peptide preparation
  • Controlled evaluation of coordinated signaling pathways
  • Reproducible laboratory conditions using standardized ratios

The single-vial structure enables efficient study of combinatory peptide systems.

Each peptide component undergoes analytical verification to ensure research-grade quality and consistency.

Testing procedures may include:

  • High-Performance Liquid Chromatography (HPLC) purity testing
  • Identity confirmation analysis
  • Batch traceability documentation
  • Controlled lyophilization processes
  • Sterile vial packaging

Certificates of Analysis are available upon request.

The Wolverine blend is supplied as a sterile lyophilized multi-peptide powder.

Storage Guidelines:

  • Store refrigerated at 2–8°C
  • Protect from light exposure
  • Avoid repeated temperature cycling
  • Handle using proper laboratory protocols

This product is supplied dry and is not pre-reconstituted.

This product is intended strictly for laboratory research purposes only.

  • Not for human consumption
  • Not for veterinary use
  • Not for therapeutic or diagnostic applications

By purchasing, the buyer acknowledges compliance with all applicable laws and regulations.

🧬 Wolverine Blend — Frequently Asked Questions (FAQ)

It is a dual-peptide research formulation combining BPC-157 and TB-500 in a single lyophilized vial for laboratory study of multi-pathway cellular signaling systems.

Researchers may use combination formulations to investigate how multiple peptides interact across different signaling pathways, enabling evaluation of coordinated biological responses.

It is supplied as a sterile lyophilized powder for laboratory research use.

No. This is a multi-component formulation and does not have a single CAS number. Individual component CAS numbers are:

  • BPC-157: 137525-51-0
  • TB-500: 77591-33-4

No. This product is strictly intended for laboratory research purposes only.

Store refrigerated at 2–8°C, protected from light, and handled according to laboratory best practices.

Each component is analytically verified to ≥99% purity, with batch-level documentation available.

COA documentation can be requested by contacting support and referencing your order details.

Product Summary

LC216 is a structured multi-component biochemical research formulation supplied as a lyophilized laboratory compound. The formulation integrates amino acids, metabolic cofactors, and vitamin-derived components that are frequently investigated in cellular metabolism, cofactor-dependent enzymatic systems, and intracellular signaling pathways.
Complex biological processes rarely operate through a single biochemical pathway. Instead, metabolic systems rely on coordinated activity between substrates, cofactors, and signaling intermediates. LC216 is designed to provide researchers with a consolidated formulation that supports investigation of these interconnected biochemical networks under controlled laboratory conditions.

The formulation includes:

  • L-Carnitine (20 mg) – studied in mitochondrial fatty-acid transport and cellular metabolic pathway models

  • L-Arginine (20 mg) – investigated as a substrate within nitric-oxide–associated signaling research systems

  • L-Methionine (25 mg) – studied in methyl donor pathways and sulfur metabolism frameworks

  • Inositol (50 mg) – examined in intracellular second-messenger signaling models

  • Choline (50 mg) – researched in phospholipid synthesis and membrane signaling systems

  • Vitamin B6 (Pyridoxine) (25 mg) – enzymatic cofactor investigated in amino-acid metabolism pathways

  • Vitamin B5 (Dexpanthenol) (25 mg) – precursor to pantothenic acid studied in coenzyme-A-dependent biochemical reactions

  • Vitamin B12 (Methylcobalamin) (1 mg) – investigated in methylation cycle and metabolic pathway research
    Together, these components allow investigators to examine how multiple biochemical cofactors interact within broader metabolic frameworks. LC216 is therefore suited for laboratory environments studying cellular metabolism, mitochondrial signaling, cofactor-supported enzymatic activity, and integrated biochemical pathways.

Product Details:

  • Form: Lyophilized multi-component research formulation

  • Composition:

    • L-Carnitine – 20 mg

    • L-Arginine – 20 mg

    • L-Methionine – 25 mg

    • Inositol – 50 mg

    • Choline – 50 mg

    • Vitamin B6 (Pyridoxine) – 25 mg

    • Vitamin B5 (Dexpanthenol) – 25 mg

    • Vitamin B12 (Methylcobalamin) – 1 mg

  • Total compound mass: 216 mg

  • Purity: ≥ 99% component-level analytical verification

  • Manufacturing: Controlled production standards

  • Certificate of Analysis (COA): Available upon request

  • Intended Use: Laboratory research only

LC216 functions as a multi-component biochemical research system rather than a single mechanistic compound. Each component contributes to distinct metabolic pathways that may interact within experimental models.

Mitochondrial Transport and Metabolic Pathways

L-Carnitine is widely investigated in mitochondrial research frameworks involving fatty-acid transport and cellular energy metabolism systems. In laboratory models, carnitine supports investigation of substrate movement across mitochondrial membranes and associated metabolic pathway dynamics.

Nitric Oxide-Associated Signaling Pathways

L-Arginine is frequently studied as a substrate within nitric-oxide–related biochemical pathways. In research environments, arginine-dependent systems are examined for their role in intracellular signaling cascades and cellular communication models.

Methylation and Sulfur Metabolism

L-Methionine is a key amino acid studied in methyl donor pathways and biochemical systems involving S-adenosylmethionine (SAMe) formation. Methylation pathways are central to numerous metabolic reactions and gene-associated regulatory mechanisms.

Vitamin B12 (methylcobalamin) is also studied in metabolic cycle frameworks involving methyl transfer reactions and enzymatic conversion pathways.

Phospholipid and Cellular Membrane Signaling

Choline and inositol are frequently examined in research involving membrane phospholipid synthesis and intracellular signaling networks. Choline participates in phosphatidylcholine research models, while inositol is commonly investigated in second-messenger signaling cascades.

Cofactor-Dependent Enzymatic Systems

Vitamin B6 (pyridoxine) functions as a cofactor in many amino-acid metabolism pathways, while Vitamin B5 (via dexpanthenol) is studied as a precursor involved in coenzyme-A–dependent biochemical reactions.

These cofactors support research into metabolic enzymatic systems and catalytic reaction networks.

Integrated Metabolic Research Model

By combining substrates and cofactors associated with several metabolic pathways, LC216 enables researchers to examine:

  • interconnected metabolic networks
  • mitochondrial pathway dynamics
  • cofactor-supported enzymatic activity
  • methylation cycle interactions
  • membrane signaling systems
  • intracellular biochemical coordination

All studies using LC216 must be conducted in accordance with appropriate laboratory and regulatory standards.

LC216 may be utilized in laboratory settings investigating:

  • metabolic pathway interaction models
  • mitochondrial function research
  • nitric-oxide signaling frameworks
  • methylation cycle and methyl-donor pathway studies
  • phospholipid membrane signaling systems
  • multi-component biochemical network analysis
  • cofactor-dependent enzymatic reactions

Researchers are responsible for designing experimental protocols and ensuring regulatory compliance.

LC216 is not a single chemical entity but a defined multi-component biochemical formulation. Each component contributes unique molecular characteristics relevant to metabolic pathway research.

The formulation includes amino acids (carnitine, arginine, methionine), signaling intermediates (inositol and choline), and vitamin-derived cofactors involved in enzymatic reactions.

This multi-component architecture allows experimental systems to investigate combined biochemical pathway activity rather than isolated molecular effects.

Form: Lyophilized powder
Total compound mass: 216 mg
Purity: ≥ 99% analytical verification
Packaging: Sterile sealed vial
Manufacturing standard: Controlled laboratory production
Storage: Refrigerated (2–8°C)

Quality Assurance and Analytical Testing

Each batch of LC216 undergoes analytical verification to support research transparency and reproducibility.

Testing protocols may include:

  • identity confirmation
  • purity verification
  • batch traceability documentation
  • controlled lyophilization procedures
  • sterile packaging verification

Certificates of Analysis are available upon request.

LC216 is supplied as a dry lyophilized research compound.

Recommended laboratory storage conditions:

  • store refrigerated at 2–8°C
  • protect from direct light exposure
  • minimize moisture exposure
  • avoid repeated temperature cycling
  • follow appropriate laboratory handling protocols

The compound is supplied dry and is not pre-reconstituted.

This product is intended strictly for laboratory research purposes only.
Not for human consumption.
Not for veterinary use.
Not for therapeutic or diagnostic applications.
By purchasing this product, the buyer acknowledges compliance with all applicable laws and research regulations.

🧪 LC216 — Frequently Asked Questions (FAQ)

LC216 is a multi-component biochemical research formulation containing amino acids, metabolic cofactors, and vitamin-derived compounds supplied in lyophilized form.

No. LC216 is a multi-component biochemical formulation rather than a peptide compound.

LC216 is supplied as a sterile lyophilized powder.

Laboratory investigations involving metabolic pathways, mitochondrial systems, cofactor-dependent enzymatic reactions, and cellular signaling networks may utilize multi-component formulations such as LC216.

No. LC216 is strictly intended for laboratory research purposes only.

Store refrigerated at 2–8°C, protected from light and moisture, and handle using proper laboratory techniques.

Certificates of Analysis may be requested by contacting support and referencing your order information.

Product Summary

LC120 is a structured multi-component laboratory research formulation containing L-Methionine (15mg), Choline Chloride (50mg), L-Carnitine (50mg), and Dexpanthenol (5mg) in a single lyophilized research vial.

This formulation is designed for investigators studying cellular metabolism pathways, methylation processes, lipid transport signaling systems, and cofactor-dependent biochemical cascades in controlled laboratory environments.

Each component within LC120 plays a distinct role in biochemical research models:

  • L-Methionine (15mg) – An essential sulfur-containing amino acid studied in methylation and metabolic pathway research
  • Choline Chloride (50mg) – Investigated in phospholipid signaling and cellular membrane pathway studies

  • L-Carnitine (50mg) – Studied in fatty acid transport and mitochondrial pathway research

  • Dexpanthenol (5mg) – A precursor to pantothenic acid investigated in coenzyme A–dependent biochemical processes

    The combined architecture of LC120 allows researchers to evaluate integrated metabolic and transport signaling frameworks within unified experimental systems.

Product Details:

– Form: Lyophilized multi-component research formulation
 – Composition:
  • L-Methionine – 15mg
  • Choline Chloride – 50mg
  • L-Carnitine – 50mg
  • Dexpanthenol – 5mg
 – Purity: ≥99% (component-level verification)
 – Manufacturing Standard: Controlled laboratory production
 – Certificate of Analysis (COA): Available upon request
 – Intended Use: Laboratory research only

LC120 combines four biochemical agents that interact with complementary metabolic pathways.

L-Methionine

L-Methionine is an essential amino acid studied for its role in methyl donor pathways, S-adenosylmethionine (SAMe) production research, and sulfur metabolism models.

Choline Chloride

Choline is investigated in phospholipid synthesis pathways, membrane structure research, and acetylcholine precursor pathway studies in laboratory models.

L-Carnitine

L-Carnitine is studied for its role in fatty acid transport mechanisms and mitochondrial pathway research frameworks.

Dexpanthenol

Dexpanthenol is a biologically active analog of pantothenic acid and is investigated in coenzyme A–dependent metabolic pathway research.

Integrated Research Model

The structured combination in LC120 enables laboratory evaluation of:

  • Methylation pathway dynamics
  • Phospholipid signaling models
  • Fatty acid transport research
  • Mitochondrial function studies
  • Cofactor-dependent biochemical cascades
  • Integrated metabolic pathway investigation

All research must be conducted in accordance with institutional and regulatory standards.

LC120 is utilized in laboratory environments for:

  • Metabolic pathway modeling
  • Lipid transport research systems
  • Methylation process investigation
  • Cellular energy metabolism frameworks
  • Cofactor interaction studies
  • Multi-component biochemical analysis

Its structured composition supports reproducible and consolidated experimental design.

Researchers may select LC120 for:

  • Integrated metabolic pathway modeling
  • Multi-component biochemical interaction studies
  • Consolidated laboratory workflow
  • Controlled proportional formulation
  • Reduced variability from separate sourcing

The defined structure supports standardized experimental conditions.

Each component in LC120 undergoes analytical verification including:

  • Purity testing and identity confirmation
  • Batch-level traceability documentation
  • Controlled manufacturing protocols
  • Sterile lyophilized packaging standards

Certificates of Analysis are available upon request for documentation transparency.

LC120 is supplied as a sterile lyophilized multi-component powder.

Storage Guidelines:

  • Store refrigerated at 2–8°C
  • Protect from light exposure
  • Avoid repeated freeze-thaw cycles
  • Follow laboratory handling protocols

The formulation is supplied dry and is not pre-reconstituted.

This product is intended strictly for laboratory research purposes only.

It is not intended for human consumption, veterinary use, therapeutic application, performance enhancement, or diagnostic purposes.

By purchasing this product, the buyer affirms compliance with all applicable research regulations and governing laws.

🧪 LC120 — Frequently Asked Questions (FAQ)

LC120 is a multi-component research formulation containing L-Methionine, Choline Chloride, L-Carnitine, and Dexpanthenol, supplied as a lyophilized powder for laboratory research.

LC120 is a structured biochemical research formulation composed of amino acid, cofactor, and nutrient-derived components used for metabolic pathway investigation in laboratory settings.

No. LC120 is strictly for laboratory research use only.

It is supplied as a sterile lyophilized powder containing all four components in defined quantities.

Store refrigerated at 2–8°C, protected from light, and handled using proper laboratory techniques.

Each component is verified through analytical testing and batch-level documentation. COA documentation is available upon request.

Combination research must comply with institutional and regulatory standards. Researchers are responsible for experimental design and compliance.

COA documentation may be requested by contacting support and referencing your order details.

Legion Peptides prioritizes analytical transparency, controlled sourcing, batch-level verification, and research-focused manufacturing standards.

Product Summary

GLOW is a multi-component research peptide formulation combining BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg) in a single lyophilized research vial. This structured blend is designed for laboratory investigators studying cellular signaling, extracellular matrix dynamics, tissue remodeling pathways, and peptide interaction models.

By integrating three structurally distinct peptide compounds into one formulation, GLOW enables researchers to examine overlapping and complementary biological signaling cascades within controlled research environments.

Each component contributes unique pathway interactions:

  • BPC-157 – Investigated in models involving cytoprotective signaling and cellular response modulation
  • GHK-Cu – A copper-binding tripeptide studied in gene expression and extracellular matrix research
  • TB-500 – A synthetic thymosin beta-4 fragment examined for its role in actin-binding protein pathways

The combined architecture of GLOW allows for multi-pathway laboratory evaluation within a single controlled peptide system.

Product Details:

– Form: Lyophilized multi-peptide formulation
 – Composition:
  • BPC-157 – 10mg
  • GHK-Cu – 50mg
  • TB-500 – 10mg
 – Purity: ≥99% (component-level HPLC verification)
 – Manufacturing Standard: Produced under controlled laboratory protocols
 – Certificate of Analysis (COA): Available upon request
 – Intended Use: Laboratory research only

GLOW combines three peptide structures that interact with distinct but potentially complementary signaling systems.

BPC-157

BPC-157 is a synthetic peptide derived from a gastric protein fragment and is studied in laboratory settings for its interaction with cytoprotective and cellular signaling pathways. Research models explore its influence on nitric oxide systems, angiogenic signaling, and tissue response frameworks.

GHK-Cu

GHK-Cu is a naturally occurring copper-binding tripeptide complex studied for its influence on gene expression patterns, extracellular matrix signaling, and protein synthesis models. It is commonly investigated in cellular regeneration and structural protein pathway research.

TB-500

TB-500 is a synthetic analog of thymosin beta-4 and is studied in relation to actin-binding protein modulation, cellular migration models, and tissue remodeling research systems.

Combined Research Significance

By integrating these three compounds into one formulation, researchers may explore:

  • Multi-pathway signaling interaction
  • Cytoskeletal regulation models
  • Extracellular matrix dynamics
  • Peptide synergy investigations
  • Integrated cellular response frameworks

All mechanistic evaluations must be conducted within regulated laboratory research settings.

GLOW is utilized in laboratory environments for investigation into:

  • Cellular signaling cascade modeling
  • Extracellular matrix pathway studies
  • Cytoskeletal protein interaction research
  • Multi-peptide combinatory analysis
  • Tissue response pathway exploration
  • Gene expression modulation frameworks

This formulation allows controlled evaluation of how structurally distinct peptides interact within integrated research models.

Researchers select structured multi-peptide formulations such as GLOW for:

  • Controlled evaluation of peptide synergy
  • Multi-mechanism pathway analysis
  • Reduction of experimental variability from separate vial handling
  • Comparative signaling cascade modeling
  • Consolidated laboratory workflow design

The unified format enables streamlined experimental design while maintaining independent peptide identity within the formulation.

Each component within GLOW undergoes analytical verification, including:

 

  • High-Performance Liquid Chromatography (HPLC) purity analysis
  • Identity confirmation testing
  • Batch-level traceability documentation
  • Controlled manufacturing standards
  • Sterile lyophilized vial packaging

Certificates of Analysis are available upon request for documentation transparency.

GLOW is supplied as a sterile lyophilized multi-peptide powder.

Storage Guidelines:

  • Store refrigerated at 2–8°C
  • Protect from direct light exposure
  • Avoid repeated freeze-thaw cycles
  • Use appropriate laboratory handling techniques

This formulation is supplied in dry lyophilized form for controlled laboratory research use.

This product is intended strictly for laboratory research purposes only.

It is not intended for human consumption, veterinary use, therapeutic application, cosmetic use, or diagnostic purposes.

By purchasing this product, the buyer affirms compliance with all applicable laws and research regulations.

🧬 GLOW — Frequently Asked Questions (FAQ)

GLOW is a multi-peptide research formulation containing BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg), supplied as a lyophilized powder for laboratory research use.

GLOW combines three distinct research peptides into one structured formulation, allowing investigators to study potential pathway interactions within a unified experimental framework.

It is supplied as a sterile lyophilized powder containing all three peptides in specified quantities.

No. GLOW is strictly intended for laboratory research purposes only.

Store refrigerated at 2–8°C, protected from light, and handled according to laboratory best practices.

Each peptide component undergoes HPLC verification to ≥99% purity. COA documentation is available upon request.

Combination research must comply with institutional and regulatory guidelines. Researchers are responsible for proper study design.

COA documentation can be requested through our support team by referencing your order details.

Legion Peptides emphasizes analytical transparency, batch-level verification, controlled sourcing, and research-focused quality assurance.

Product Summary

GLOW50 is a structured multi-peptide research formulation containing BPC-157 (5mg), GHK-Cu (35mg), and TB-500 (10mg) in a single lyophilized vial. This formulation is designed for laboratory investigators studying coordinated cellular signaling systems, extracellular matrix pathways, and cytoskeletal protein dynamics within controlled experimental environments.

GLOW50 represents a calibrated variation of multi-peptide research blends, offering adjusted component ratios for researchers who require alternative proportional structures in combinatory peptide analysis.

Each component contributes distinct mechanistic research relevance:

  • BPC-157 (5mg) – Studied in cellular signaling and nitric oxide pathway research models
  • GHK-Cu (35mg) – A copper-binding tripeptide investigated in gene expression and extracellular matrix research frameworks
  • TB-500 (10mg) – A thymosin beta-4 analog examined for actin-binding protein interaction and cytoskeletal pathway studies

The adjusted composition of GLOW50 allows researchers to evaluate pathway interaction under modified peptide ratios, supporting comparative laboratory investigations across multi-peptide systems.

Product Details:

– Form: Lyophilized multi-peptide formulation
 – Composition:
  • BPC-157 – 5mg
  • GHK-Cu – 35mg
  • TB-500 – 10mg
 – Purity: ≥99% (component-level HPLC verified)
 – Manufacturing Standard: Controlled laboratory production protocols
 – Certificate of Analysis (COA): Available upon request
 – Intended Use: Laboratory research only

GLOW50 integrates three peptides that interact with complementary biological signaling systems.

BPC-157

BPC-157 is investigated in laboratory models for its interaction with nitric oxide systems and cellular response modulation pathways.

GHK-Cu

GHK-Cu is a copper-binding tripeptide studied for its influence on gene expression patterns, extracellular matrix signaling cascades, and structural protein research frameworks.

TB-500

TB-500, a thymosin beta-4 fragment analog, is examined in relation to actin-binding protein modulation and cytoskeletal organization research models.

Combined Mechanistic Framework

By combining these components at adjusted ratios, GLOW50 enables research into:

  • Multi-pathway signaling interaction
  • Cytoskeletal and extracellular matrix coordination
  • Peptide ratio comparison studies
  • Structural signaling cascade modeling
  • Controlled combinatory peptide investigations

All studies must comply with institutional research standards and regulatory requirements.

GLOW50 is utilized in laboratory environments for:

  • Multi-peptide interaction analysis
  • Cellular signaling cascade modeling
  • Extracellular matrix pathway research
  • Cytoskeletal protein dynamics investigation
  • Peptide ratio comparison studies
  • Integrated biological pathway evaluation

Its adjusted composition supports comparative analysis relative to higher-concentration blend formulations.

Researchers may select GLOW50 for:

  • Controlled evaluation of modified peptide ratios
  • Comparative combinatory research
  • Consolidated experimental workflow
  • Reduced handling variability from separate vials
  • Structured multi-mechanism pathway modeling

The defined composition allows consistency and reproducibility within experimental frameworks.

Each peptide component in GLOW50 undergoes analytical verification including:

  • High-Performance Liquid Chromatography (HPLC) purity testing
  • Identity confirmation analysis
  • Batch-level traceability documentation
  • Controlled lyophilization standards
  • Sterile sealed vial packaging

Certificates of Analysis are available upon request to verify analytical integrity.

GLOW50 is supplied as a sterile lyophilized multi-peptide powder.

Storage Guidelines:

  • Store refrigerated at 2–8°C
  • Protect from light exposure
  • Avoid repeated freeze-thaw cycles
  • Follow proper laboratory handling procedures

The formulation is supplied dry and is not pre-reconstituted.

This product is intended strictly for laboratory research purposes only.

It is not intended for human consumption, veterinary use, therapeutic application, cosmetic use, or diagnostic purposes.

By purchasing this product, the buyer affirms compliance with all applicable research regulations and governing laws.

🧬 GLOW50 — Frequently Asked Questions (FAQ)

GLOW50 is a multi-peptide research formulation containing BPC-157 (5mg), GHK-Cu (35mg), and TB-500 (10mg) supplied as a lyophilized powder for laboratory research.

GLOW50 contains adjusted concentrations of BPC-157 and GHK-Cu while maintaining TB-500 at 10mg. This allows researchers to investigate pathway interaction under modified peptide ratios.

It is supplied as a sterile lyophilized powder containing all three peptides in specified quantities.

No. GLOW50 is strictly for laboratory research use only.

Store refrigerated at 2–8°C, protected from light, and handled using proper laboratory techniques.

Each component is verified to ≥99% purity via HPLC testing. COA documentation is available upon request.

Combination research must adhere to institutional and regulatory guidelines. Researchers are responsible for compliance.

COA documentation may be requested by contacting support and referencing your order information.

Legion Peptides maintains strict analytical verification, transparent documentation, controlled sourcing, and research-focused manufacturing standards.

Product Summary

KLOW is an advanced multi-component research peptide formulation integrating four structurally distinct peptides into a single lyophilized vial: BPC-157 (10mg), GHK-Cu (50mg), TB-500 (10mg), and KPV (10mg).

This structured blend is designed for laboratory investigators examining cellular signaling cascades, extracellular matrix dynamics, cytoskeletal protein interaction, inflammatory signaling pathways, and integrated peptide interaction models.

By combining peptides with complementary mechanistic research profiles, KLOW allows for structured investigation into overlapping and coordinated biological signaling systems within controlled laboratory environments.

Each component contributes a distinct area of pathway investigation:

  • BPC-157 – Studied in cytoprotective signaling and nitric oxide pathway research models
  • GHK-Cu – A copper-binding tripeptide investigated in gene expression and extracellular matrix signaling frameworks
  • TB-500 – A thymosin beta-4 analog studied for actin-binding protein interaction and cytoskeletal regulation
  • KPV – A tripeptide fragment (Lysine-Proline-Valine) investigated for its role in immune signaling modulation research

The integration of these peptides into one formulation allows researchers to explore multi-pathway interaction within a unified experimental structure.

Product Details:

– Form: Lyophilized multi-peptide formulation
 – Composition:
  • BPC-157 – 10mg
  • GHK-Cu – 50mg
  • TB-500 – 10mg
  • KPV – 10mg
 – Purity: ≥99% (component-level HPLC verified)
 – Manufacturing Standard: Controlled laboratory production
 – Certificate of Analysis (COA): Available upon request
 – Intended Use: Laboratory research only

KLOW combines four peptides that interact with distinct but potentially complementary biological signaling systems.

BPC-157

BPC-157 is studied in laboratory environments for its interaction with nitric oxide signaling pathways and cellular response regulation models.

GHK-Cu

GHK-Cu is a copper-binding tripeptide investigated for its influence on gene expression patterns, extracellular matrix protein research, and structural signaling cascades.

TB-500

TB-500, a thymosin beta-4 analog, is studied for its interaction with actin-binding proteins and cytoskeletal modulation pathways in cellular migration models.

KPV

KPV is a naturally derived tripeptide fragment studied in laboratory settings for its role in inflammatory signaling pathway research and immune response modulation models.

Integrated Research Framework

The structured combination of these four peptides allows researchers to examine:

  • Multi-layered signaling cascade interaction
  • Cytoskeletal and extracellular matrix coordination
  • Gene expression pathway modulation
  • Immune signaling research models
  • Peptide synergy and combinatory investigations

All investigations must comply with institutional laboratory standards and applicable regulatory frameworks.

KLOW is utilized in laboratory environments for investigation into:

  • Multi-peptide signaling interaction studies
  • Cellular pathway cross-communication models
  • Extracellular matrix signaling research
  • Cytoskeletal protein modulation analysis
  • Immune signaling pathway research
  • Integrated biological response frameworks

This formulation supports structured evaluation of how diverse peptide classes interact within complex research systems.

Researchers select advanced multi-peptide formulations such as KLOW for:

  • Evaluation of multi-pathway synergy
  • Controlled combinatory research design
  • Consolidated experimental handling
  • Integrated receptor and protein interaction modeling
  • Reduced variability from separate peptide sourcing

The single-vial structure allows streamlined experimental workflow while maintaining component-level analytical integrity.

Each peptide component within KLOW undergoes analytical verification including:

  • High-Performance Liquid Chromatography (HPLC) purity testing
  • Identity confirmation analysis
  • Batch-level traceability documentation
  • Controlled lyophilization procedures
  • Sterile sealed vial packaging

Certificates of Analysis are available upon request to verify analytical standards and batch integrity.

KLOW is supplied as a sterile lyophilized multi-peptide powder.

Storage Guidelines:

  • Store refrigerated at 2–8°C
  • Protect from direct light
  • Avoid repeated freeze-thaw exposure
  • Maintain proper laboratory handling protocols

This compound is supplied in dry lyophilized form and is not pre-reconstituted.

This product is intended strictly for laboratory research purposes only.

It is not intended for human consumption, veterinary use, therapeutic application, cosmetic application, or diagnostic purposes.

By purchasing this product, the buyer affirms compliance with all applicable research and regulatory standards.

🧬 KLOW — Frequently Asked Questions (FAQ)

KLOW is a four-component multi-peptide research formulation containing BPC-157 (10mg), GHK-Cu (50mg), TB-500 (10mg), and KPV (10mg), supplied in lyophilized form for laboratory research.

KLOW includes an additional peptide component, KPV (10mg), expanding its research scope to include inflammatory signaling pathway investigation alongside extracellular matrix and cytoskeletal research models.

It is supplied as a sterile lyophilized powder containing all four peptides in defined quantities.

No. KLOW is strictly for laboratory research use only.

Store refrigerated at 2–8°C, protected from light, and handled according to laboratory best practices.

Each component is verified to ≥99% purity through HPLC testing. COA documentation is available upon request.

Combination research must adhere to institutional and regulatory guidelines. Researchers are responsible for experimental design and compliance.

COA documentation may be requested by contacting support and referencing your order details.

Legion Peptides prioritizes batch-level analytical verification, structured sourcing, transparent documentation, and research-focused quality standards.

Product Summary

KLOW70 is a structured multi-peptide research formulation integrating BPC-157 (10mg), GHK-Cu (50mg), and KPV (10mg) in a single lyophilized vial. This formulation is designed for laboratory investigators studying coordinated cellular signaling pathways, extracellular matrix regulation, immune signaling cascades, and multi-peptide interaction models.

By combining three structurally distinct peptides into one controlled formulation, KLOW70 allows researchers to examine overlapping and complementary biological signaling systems within unified experimental environments.

Each component contributes distinct mechanistic research relevance:

  • BPC-157 (10mg) – Studied in cellular signaling and nitric oxide pathway research models
  • GHK-Cu (50mg) – A copper-binding tripeptide investigated in gene expression and extracellular matrix signaling frameworks
  • KPV (10mg) – A tripeptide fragment studied in immune signaling and inflammatory pathway research models

The absence of cytoskeletal-focused thymosin analogs distinguishes KLOW70 from other combinatory blends, making it suited for researchers prioritizing extracellular matrix dynamics and immune pathway investigation.

Product Details:

– Form: Lyophilized multi-peptide formulation
 – Composition:
  • BPC-157 – 10mg
  • GHK-Cu – 50mg
  • KPV – 10mg
 – Purity: ≥99% (component-level HPLC verified)
 – Manufacturing Standard: Controlled laboratory production protocols
 – Certificate of Analysis (COA): Available upon request
 – Intended Use: Laboratory research only

KLOW70 integrates three peptides that interact with complementary biological signaling systems.

BPC-157

BPC-157 is investigated in laboratory models for its interaction with nitric oxide signaling pathways and cellular response modulation research frameworks.

GHK-Cu

GHK-Cu is a naturally occurring copper-binding tripeptide studied for its influence on gene expression regulation, extracellular matrix protein research, and structural signaling cascades.

KPV

KPV (Lysine-Proline-Valine) is a tripeptide fragment derived from α-MSH and is investigated for its role in immune signaling research and inflammatory pathway modulation models.

Integrated Mechanistic Research Framework

The combined architecture of KLOW70 allows researchers to examine:

  • Extracellular matrix signaling coordination
  • Gene expression pathway interaction
  • Immune signaling cascade modeling
  • Nitric oxide system research
  • Multi-peptide synergy investigations

All mechanistic evaluations must be conducted within regulated laboratory environments.

KLOW70 is utilized in laboratory environments for:

  • Multi-peptide interaction analysis
  • Cellular signaling cascade modeling
  • Extracellular matrix pathway research
  • Immune pathway signaling investigation
  • Peptide synergy evaluation
  • Gene expression modulation studies

The structured composition supports reproducible experimental design and consolidated research workflows.

Researchers may select KLOW70 for:

  • Focused extracellular matrix and immune pathway modeling
  • Multi-pathway synergy investigation
  • Controlled combinatory research design
  • Reduced handling variability from separate peptide sourcing
  • Consolidated experimental execution

The unified formulation allows structured evaluation of pathway interaction while maintaining component-level analytical transparency.

Each peptide component within KLOW70 undergoes analytical verification including:

  • High-Performance Liquid Chromatography (HPLC) purity testing
  • Identity confirmation analysis
  • Batch-level traceability documentation
  • Controlled lyophilization procedures
  • Sterile sealed vial packaging

Certificates of Analysis are available upon request to verify analytical standards.

KLOW70 is supplied as a sterile lyophilized multi-peptide powder.

Storage Guidelines:

  • Store refrigerated at 2–8°C
  • Protect from direct light
  • Avoid repeated freeze-thaw cycles
  • Maintain proper laboratory handling techniques

This formulation is supplied dry and is not pre-reconstituted.

This product is intended strictly for laboratory research purposes only.

It is not intended for human consumption, veterinary use, therapeutic application, cosmetic use, or diagnostic purposes.

By purchasing this product, the buyer affirms compliance with all applicable research regulations and governing laws.

🧬 KLOW70 — Frequently Asked Questions (FAQ)

KLOW70 is a multi-peptide research formulation containing BPC-157 (10mg), GHK-Cu (50mg), and KPV (10mg), supplied as a lyophilized powder for laboratory research.

KLOW70 does not contain TB-500 and instead focuses on extracellular matrix, nitric oxide, and immune signaling research pathways through its three-component structure.

It is supplied as a sterile lyophilized powder containing all three peptides in defined quantities.

No. KLOW70 is strictly intended for laboratory research purposes only.

Store refrigerated at 2–8°C, protected from light, and handled according to laboratory best practices.

Each component is verified to ≥99% purity via HPLC testing. COA documentation is available upon request.

Combination research must comply with institutional and regulatory standards. Researchers are responsible for proper study design.

COA documentation may be requested by contacting support and referencing your order details.

Legion Peptides prioritizes analytical transparency, controlled sourcing, batch-level verification, and research-focused quality standards.

Product Summary

Glutathione (GSH) is a naturally occurring tripeptide composed of glutamine, cysteine, and glycine. It plays a central role in intracellular redox regulation and oxidative balance research within cellular systems.

As a key antioxidant molecule, glutathione is widely studied in laboratory environments for its involvement in:

  • Cellular redox homeostasis
  • Reactive oxygen species (ROS) regulation
  • Enzyme-dependent detoxification pathways
  • Mitochondrial signaling systems
  • Oxidative stress research models

Reduced glutathione (GSH) serves as a primary intracellular antioxidant and is fundamental to biochemical studies involving cellular protection mechanisms and redox cycling frameworks.

Product Details:

– Form: Lyophilized reduced glutathione (GSH)
 – Purity: ≥99% (analytically verified)
 – Molecular Classification: Tripeptide antioxidant
 – Certificate of Analysis (COA): Available upon request
 – Intended Use: Laboratory research only

Glutathione functions as a central redox-active molecule within cellular systems.

Redox Cycling

Glutathione participates in redox reactions by donating electrons to neutralize reactive oxygen species, becoming oxidized to glutathione disulfide (GSSG) in the process. It is then recycled back to its reduced form via glutathione reductase in NADPH-dependent reactions.

This redox cycle is studied in:

  • Oxidative stress modeling
  • Mitochondrial function research
  • Enzymatic detoxification pathway studies
Enzyme Interactions

Glutathione is involved in:

  • Glutathione peroxidase systems
  • Glutathione S-transferase pathways
  • Cellular detoxification cascade research
Cellular Signaling

Research models investigate glutathione’s role in:

  • Redox-sensitive transcription factor regulation
  • Mitochondrial signaling pathways
  • Intracellular antioxidant balance
  • Protein thiol regulation studies

All research must comply with institutional and regulatory guidelines.

Glutathione is utilized in laboratory environments for:

  • Oxidative stress pathway research
  • Redox balance modeling
  • Antioxidant system studies
  • Mitochondrial function investigation
  • Enzyme-mediated detoxification research
  • Cellular signaling cascade analysis

Its widespread role in intracellular processes makes it a foundational compound in biochemical research systems.

Glutathione is composed of:

  • Glutamate
  • Cysteine
  • Glycine

Its unique gamma-peptide bond between glutamate and cysteine contributes to its stability and biological activity in redox reactions.

Reduced glutathione (GSH) differs structurally from its oxidized form (GSSG), allowing dynamic cycling in cellular redox systems.

Each batch of Glutathione undergoes analytical verification including:

  • High-Performance Liquid Chromatography (HPLC) purity testing
  • Identity confirmation analysis
  • Batch-level traceability documentation
  • Controlled lyophilization processes
  • Sterile sealed packaging

Certificates of Analysis are available upon request.

Glutathione is supplied as a sterile lyophilized powder.

Storage Guidelines:

  • Store refrigerated at 2–8°C
  • Protect from light exposure
  • Minimize moisture contact
  • Avoid repeated freeze-thaw cycles
  • Follow appropriate laboratory handling protocols

The compound is supplied dry and is not pre-reconstituted.

This product is intended strictly for laboratory research purposes only.

It is not intended for human consumption, veterinary use, therapeutic application, cosmetic use, or diagnostic purposes.

By purchasing this product, the buyer affirms compliance with all applicable research regulations and governing laws.

🧬 Glutathione — Frequently Asked Questions (FAQ)

Glutathione is a naturally occurring tripeptide involved in cellular redox regulation and antioxidant pathway research.

It is supplied as reduced glutathione (GSH) in sterile lyophilized powder form for laboratory research.

Yes. Glutathione is a tripeptide composed of glutamate, cysteine, and glycine.

No. This product is strictly intended for laboratory research use only.

Each batch is analytically verified to ≥99% purity. COA documentation is available upon request.

Store refrigerated at 2–8°C, protected from light and moisture, and handled according to laboratory protocols.

Combination research must comply with institutional and regulatory guidelines.

COA documentation may be requested by contacting support with your order details.

COA documentation may be requested through our support team by referencing your order details.

Product Summary

Cagrilintide is a long-acting amylin analog developed to study appetite regulation, delayed gastric emptying, and energy homeostasis. As an investigational peptide, it mimics the natural hormone amylin, co-secreted with insulin from pancreatic β-cells, and plays a critical role in postprandial glucose control and satiety signaling. Cagrilintide is often researched alone or in combination with GLP-1 analogs to investigate synergistic effects in weight regulation and metabolic syndromes.

– Form: Lyophilized peptide
– Purity: ≥99%
– Origin: Manufactured and tested in the USA
– Certifications: Certificate of Analysis (COA) included with every order

Cagrilintide binds to amylin receptors in the brain and gastrointestinal tract, where it:
– Slows gastric emptying to prolong digestion and nutrient absorption
– Increases satiety signals via the area postrema in the brainstem
– Decreases food intake and modulates caloric consumption
– Works synergistically with GLP-1 analogs to enhance metabolic benefits

– Amylin receptor signaling studies
– Appetite suppression and satiety models
– Delayed gastric emptying and gut-brain axis research
– Obesity and weight loss combination therapies
– Synergy studies with GLP-1 receptor agonists

– Long-acting formulation for sustained receptor activation
– Ideal for combination protocols with incretin-based analogs
– Validated in animal and translational models of obesity
– Ultra-high purity for reproducibility in controlled studies

Each vial is:
– Manufactured in a GMP-compliant U.S. facility
– Accompanied by a Certificate of Analysis (COA)
– Subjected to HPLC and mass spectrometry verification
– Shipped from within the United States for quality control

– Contents: 5mg of lyophilized Cagrilintide peptide
– Appearance: White/off-white powder
– Solubility: Sterile bacteriostatic water or acetic acid recommended
– Storage: Store lyophilized vial at -20°C; reconstituted solution stable up to 30 days when refrigerated
*For laboratory research use only. Not intended for human or veterinary use.*

– This product is sold for research purposes only
– Not for human consumption, injection, or diagnostic procedures
– Must be handled by qualified professionals in accordance with institutional and governmental safety guidelines

🧬 Cagrilintide — Frequently Asked Questions (FAQ)

Cagrilintide is a long-acting amylin analog used in research to explore its effects on appetite regulation, gastric emptying, and body weight modulation. It mimics the endogenous hormone amylin, which is co-secreted with insulin from pancreatic beta cells.

Cagrilintide binds to the amylin receptor complex (calcitonin receptor + RAMP proteins), influencing satiety signals in the brain. Research shows it slows gastric emptying, reduces food intake, and may enhance the weight loss effects of other peptides when co-administered, particularly GLP-1 receptor agonists.

Our Cagrilintide is provided as a lyophilized powder in sterile, sealed vials for research use only. Each vial is manufactured and lab-tested in the USA to ensure purity and consistency.

No. Cagrilintide sold by Legion Peptides is strictly for in vitro and in vivo laboratory research. It is not intended for human or veterinary use, and any off-label application is strictly prohibited.

Store lyophilized Cagrilintide at -20°C in a desiccated environment. Once reconstituted, it should be used promptly or stored at 2–8°C and used within a limited time, depending on research protocols.

Each batch of Cagrilintide is ≥98% pure, verified by HPLC and Mass Spectrometry. A certificate of analysis (COA) is included with every order, detailing lab testing results.

Due to its stable lyophilized form, Cagrilintide is shipped in temperature-resistant packaging. Cold-chain shipping is available for bulk or sensitive research orders upon request.

Many researchers explore synergistic effects of Cagrilintide with GLP-1 agonists like Semaglutide or Tirzepatide. However, all combinatory use must be conducted within approved research protocols and settings.

You may select the product from the dropdown menu on our Lab Test Results page, enter your name and email, and we’ll send the Certificate of Analysis directly to your inbox.

We deliver lab-tested, U.S.-made, and research-pure Cagrilintide with fast shipping and unmatched support. Every batch is verified for identity and integrity, ensuring your research starts with the highest-quality compound.

Product Summary

Retatrutide is a cutting-edge tri-agonist peptide designed to activate the GLP-1, GIP, and glucagon receptors. It represents a next-generation investigational tool for the study of obesity, insulin resistance, and advanced metabolic syndromes. By engaging three key incretin and glucoregulatory pathways, Retatrutide offers a powerful platform for researchers to study weight reduction, glycemic control, and energy balance across multiple mechanisms of action.

– Form: Lyophilized peptide
– Purity: ≥99%
– Origin: Manufactured and tested in the USA
– Certifications: Certificate of Analysis (COA) included with every order

Retatrutide acts as a potent tri-agonist for:
– GLP-1 Receptor: Enhances glucose-dependent insulin secretion and reduces appetite
– GIP Receptor: Supports insulin release and improves insulin sensitivity
– Glucagon Receptor: Increases energy expenditure and lipid metabolism

The combination of these actions promotes enhanced satiety, improved glycemic profiles, and sustained energy utilization, making it an advanced candidate for metabolic research.

– Tri-pathway incretin/glucagon signaling studies
– Advanced obesity and metabolic syndrome models
– Energy expenditure and thermogenesis
– Insulin resistance and lipid metabolism
– Novel anti-diabetic agent development

– Multi-receptor targeting for synergistic outcomes
– Investigational profile for next-gen weight management models
– Robust pharmacological data for translational studies
– Exceptional purity for experimental consistency

Each vial is:
– Manufactured in a GMP-compliant U.S. facility
– Accompanied by a Certificate of Analysis (COA)
– Subjected to HPLC and mass spectrometry verification
– Shipped from within the United States for quality control

– Contents: 5mg of lyophilized Retatrutide peptide
– Appearance: White/off-white powder
– Solubility: Sterile bacteriostatic water or acetic acid recommended
– Storage: Store lyophilized vial at -20°C; reconstituted solution stable up to 30 days when refrigerated
*For laboratory research use only. Not intended for human or veterinary use.*

– This product is sold for research purposes only
– Not for human consumption, injection, or diagnostic procedures
– Must be handled by qualified professionals in accordance with institutional and governmental safety guidelines

🧬 Retatrutide — Frequently Asked Questions (FAQ)

Retatrutide is a novel triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors. It is under investigation for its effects on glucose metabolism, energy expenditure, and body weight regulation.

Retatrutide activates GLP-1 and GIP receptors to enhance insulin secretion and reduce appetite, while glucagon receptor activation increases energy expenditure. This multi-pathway approach may yield synergistic metabolic effects in research models.

Retatrutide from Legion Peptides is available as a lyophilized powder in sterile vials for laboratory research use only. Each vial is synthesized and tested in the United States.

No. Retatrutide is strictly for laboratory research and is not intended for human or veterinary consumption.

Store lyophilized Retatrutide at -20°C in a dry, dark location. Once reconstituted, it should be refrigerated at 2–8°C and used promptly based on lab stability protocols.

All Retatrutide batches are >98% pure as confirmed by HPLC and Mass Spectrometry. Each purchase includes a certificate of analysis for quality assurance.

Yes. While our standard packaging ensures stability during transit, cold-chain shipping is available upon request for sensitive or bulk orders.

Some research protocols explore the use of Retatrutide in combination with other incretin-based therapies. All such studies must be conducted under appropriate lab protocols.

Go to our Lab Test Results page, choose Retatrutide from the dropdown, and enter your name and email to receive the Certificate of Analysis directly.

Legion Peptides provides U.S.-made, research-grade Retatrutide with fast shipping, transparent testing, and superior support. Every vial is backed by lab documentation and purity verification.

Product Summary

Tirzepatide is a novel dual agonist of the GLP-1 and GIP receptors, engineered to provide a synergistic approach to metabolic regulation. This next-generation incretin mimetic is at the forefront of research in obesity, insulin resistance, and type 2 diabetes. By targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, Tirzepatide enhances insulin secretion, suppresses glucagon, and modulates appetite and gastric motility.

– Form: Lyophilized peptide
– Purity: ≥99%
– Origin: Manufactured and tested in the USA
– Certifications: Certificate of Analysis (COA) included with every order

Tirzepatide is a synthetic peptide designed to activate both GLP-1 and GIP receptors. Upon binding:
– Stimulates insulin secretion in a glucose-dependent manner
– Suppresses glucagon during hyperglycemia
– Delays gastric emptying to promote satiety
– Enhances adipocyte insulin sensitivity
– Reduces appetite via central nervous system pathways

– Dual incretin pathway investigation
– Obesity and type 2 diabetes models
– Appetite and food intake modulation
– Insulin and glucagon dynamics
– Cardiometabolic risk factor studies

– Dual receptor targeting provides enhanced efficacy
– Long-acting formulation mimics clinical pharmacokinetics
– Validated in preclinical and translational models
– High purity for consistent and reproducible outcomes

Each vial is:
– Manufactured in a GMP-compliant U.S. facility
– Accompanied by a Certificate of Analysis (COA)
– Subjected to HPLC and mass spectrometry verification
– Shipped from within the United States for quality control

– Contents: 5mg of lyophilized Tirzepatide peptide
– Appearance: White/off-white powder
– Solubility: Sterile bacteriostatic water or acetic acid recommended
– Storage: Store lyophilized vial at -20°C; reconstituted solution stable up to 30 days when refrigerated
*For laboratory research use only. Not intended for human or veterinary use.*

– This product is sold for research purposes only
– Not for human consumption, injection, or diagnostic procedures
– Must be handled by qualified professionals in accordance with institutional and governmental safety guidelines

Tirzepatide – Frequently Asked Questions

Tirzepatide is a dual GIP and GLP-1 receptor agonist being researched for its effects on glucose regulation, insulin secretion, and body weight modulation. It mimics the incretin hormones to enhance insulin release and reduce appetite.

Tirzepatide activates both GIP and GLP-1 receptors. GIP enhances glucose-dependent insulin release, while GLP-1 delays gastric emptying, suppresses glucagon, and promotes satiety. The dual mechanism may offer synergistic benefits for metabolic research.

Legion Peptides provides Tirzepatide as a lyophilized powder in sterile vials for laboratory research only. It is synthesized and tested in certified U.S. laboratories.

No. Tirzepatide sold by Legion Peptides is strictly for laboratory research use. It is not intended for human or veterinary consumption.

Keep lyophilized Tirzepatide at -20°C in a dry, dark place. After reconstitution, store between 2–8°C and use according to your lab’s stability guidelines.

Our Tirzepatide is >98% pure as verified by HPLC and Mass Spectrometry. Each order includes a certificate of analysis for full transparency.

Yes, we offer cold-chain shipping on request, though our standard packaging is designed to maintain stability during normal transit conditions.

Tirzepatide is often evaluated alongside other incretin-based peptides like Semaglutide or Cagrilintide. Any combinatory studies must follow research-approved protocols.

Navigate to our Lab Test Results page, select Tirzepatide, and provide your name and email to receive the lab documentation.

Our Tirzepatide is lab-tested, research-grade, and manufactured in the USA. Backed by fast fulfillment and excellent support, we prioritize quality and consistency.

Product Summary

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist developed for the study of metabolic regulation, glucose homeostasis, and appetite control. This research compound mimics endogenous incretin hormones to promote insulin secretion and suppress glucagon release in a glucose-dependent manner. Extensively studied for its effects on weight modulation and type 2 diabetes pathways, Semaglutide represents a cutting-edge tool for investigators exploring obesity, insulin sensitivity, and endocrine signaling.

– Form: Lyophilized peptide
– Purity: ≥99%
– Origin: Manufactured and tested in the USA
– Certifications: Certificate of Analysis (COA) included with every order

Semaglutide selectively binds to and activates the GLP-1 receptor, a G protein-coupled receptor expressed in the pancreas and central nervous system. Upon activation:
– Enhances insulin secretion from pancreatic β-cells in a glucose-dependent manner
– Suppresses glucagon release during hyperglycemia
– Slows gastric emptying, leading to prolonged satiety
– Reduces appetite via central hypothalamic pathways

– Metabolic disease modeling
– Appetite and weight regulation studies
– Insulin-glucose homeostasis research
– Pancreatic β-cell activity
– Neuroendocrine signaling pathways

– Stable GLP-1 analog with extended half-life
– Consistent bioavailability in vivo and in vitro
– Well-documented clinical analog for translational studies
– High reproducibility across experimental setups

Each vial is:
– Manufactured in a GMP-compliant U.S. facility
– Accompanied by a Certificate of Analysis (COA)
– Subjected to HPLC and mass spectrometry verification
– Shipped from within the United States for quality control

– Contents: 5mg of lyophilized Semaglutide peptide
– Appearance: White/off-white powder
– Solubility: Sterile bacteriostatic water or acetic acid recommended
– Storage: Store lyophilized vial at -20°C; reconstituted solution stable up to 30 days when refrigerated
*For laboratory research use only. Not intended for human or veterinary use.*

– This product is sold for research purposes only
– Not for human consumption, injection, or diagnostic procedures
– Must be handled by qualified professionals in accordance with institutional and governmental safety guidelines

🧬 Semaglutide — Frequently Asked Questions (FAQ)

Semaglutide is a GLP-1 receptor agonist commonly researched for its effects on glucose metabolism, insulin secretion, and appetite regulation. It is a synthetic analog of human GLP-1 with extended half-life for weekly dosing.

Semaglutide binds to GLP-1 receptors in the pancreas, brain, and GI tract. This stimulates insulin secretion, suppresses glucagon release, delays gastric emptying, and reduces appetite. These effects contribute to improved glycemic control and potential weight loss in preclinical models.

Our Semaglutide is offered as a lyophilized powder in sterile, sealed vials for laboratory research purposes only. Each batch is produced and tested in the USA.

No. Semaglutide sold by Legion Peptides is strictly intended for laboratory research. It is not approved for human or veterinary use.

Lyophilized Semaglutide should be stored at -20°C in a dry environment. Once reconstituted, store at 2–8°C and use promptly, following your lab’s guidelines for stability.

Every vial is >98% pure, verified by HPLC and Mass Spectrometry. A certificate of analysis (COA) is included with each purchase.

Semaglutide is shipped in temperature-resistant packaging to maintain integrity. Cold-chain shipping is available for bulk or high-sensitivity orders upon request.

Semaglutide is often studied alongside compounds like Cagrilintide and Tirzepatide for synergistic metabolic effects. Always follow approved research protocols when combining peptides.

Visit our Lab Test Results page, select Semaglutide from the dropdown, and submit your name and email to receive the COA directly.

Our Semaglutide is U.S.-made, lab-verified, and backed by superior customer service. Fast shipping, premium purity, and research-only quality make us the preferred choice.

Product Summary

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) used in advanced research focused on metabolic and endocrine modulation. It stimulates the pituitary gland to produce and release endogenous growth hormone (GH), which in turn elevates IGF-1 levels. Tesamorelin is unique due to its high specificity for GHRH receptors and a relatively long half-life compared to natural GHRH, allowing for consistent GH pulsatility. It is widely studied for its role in fat metabolism, muscle preservation, and endocrine-related disorders.

– Form: Lyophilized peptide
– Purity: >99%
– Origin: Manufactured and tested in the USA
– Certifications: Certificate of Analysis (COA) included

Tesamorelin binds to GHRH receptors on the pituitary gland, initiating a cascade that results in the pulsatile release of growth hormone. This GH secretion leads to increased IGF-1 production in the liver and peripheral tissues. The elevated IGF-1 levels support protein synthesis, reduce visceral adipose tissue, and enhance metabolic efficiency without directly increasing insulin levels or cortisol.

– Fat loss and visceral adiposity reduction
– Muscle preservation during caloric restriction
– Endocrine and pituitary axis modulation
– Metabolic syndrome and lipodystrophy models
– IGF-1 elevation and downstream growth effects

– Highly selective GHRH analog with prolonged half-life
– Promotes natural, rhythmic GH and IGF-1 release
– Minimal side effects on insulin and cortisol balance
– Clinically validated for reducing visceral adipose tissue

Each vial is:
– Manufactured in a GMP-compliant U.S. facility
– Supplied with a Certificate of Analysis (COA)
– Verified via mass spectrometry and HPLC for identity and purity
– Securely shipped from the USA

– Contents: 2mg lyophilized Tesamorelin peptide
– Appearance: White/off-white powder
– Solubility: Reconstitute with sterile bacteriostatic water
– Storage: Store powder at -20°C; use reconstituted product within 30 days under refrigeration
*For laboratory research use only. Not for human or animal consumption.*

– For research purposes only
– Not intended for therapeutic, diagnostic, or medical use
– Researchers must comply with all legal and institutional guidelines

🧬 Tesamorelin — Frequently Asked Questions (FAQ)

Tesamorelin is a synthetic peptide that mimics the body’s natural growth hormone-releasing hormone (GHRH). Researchers use it to investigate its role in stimulating growth hormone (GH) secretion, improving fat metabolism, and enhancing body composition. It’s gaining traction in metabolic and anti-aging research models.

Tesamorelin binds to GHRH receptors in the anterior pituitary gland, triggering a cascade that results in the release of endogenous growth hormone. This GH then stimulates the liver to produce insulin-like growth factor 1 (IGF-1), a critical mediator for tissue repair, fat metabolism, and muscle development. Researchers study this mechanism to better understand hormone regulation and fat redistribution.

Our Tesamorelin is supplied as a lyophilized (freeze-dried) powder in sterile, single-use vials. It’s designed exclusively for laboratory research and meets rigorous U.S. purity and sterility standards. Each vial is packaged for easy handling and consistent dosing in preclinical settings.

To maintain stability and potency, store the lyophilized vial at -20°C in a dry, dark place. After reconstitution, refrigerate at 2–8°C and use within your lab’s recommended timeframe. Proper storage helps preserve the peptide’s structural integrity for accurate research results.

Every batch of Tesamorelin we produce is ≥98% pure, verified through HPLC and Mass Spectrometry. You’ll receive a full Certificate of Analysis (COA) with your order, detailing the exact purity level and confirming identity. We pride ourselves on providing research-grade compounds you can trust.

Yes, in many research models Tesamorelin is used in conjunction with other growth hormone secretagogues or metabolic agents to study synergistic effects. However, all such use must remain within the boundaries of approved research protocols.

It’s simple. Just visit our Lab Test Results page, choose Tesamorelin from the dropdown, and enter your email address. We’ll send your batch-specific COA directly to your inbox for complete transparency.

Legion Peptides is committed to purity, reliability, and value. Our Tesamorelin is U.S.-manufactured, ≥98% pure, and lab-tested for each batch. Every order includes a COA, and we back our pricing with a Price Match Guarantee. If you find the same grade for less, we’ll match it. Plus, enjoy responsive support and same-day shipping from our New York facility.

Legion Peptides

PROFESSIONAL RESEARCH PROTOCOLS

Tesamorelin Dosage Protocol (5 mg, 10 mg & 20 mg Vials)

Quickstart Highlights

Tesamorelin is a synthetic 44-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH)[1]. It stimulates endogenous growth hormone release and raises IGF-1 levels, leading to enhanced lipolysis and metabolic benefits[2]. Tesamorelin is FDA-approved for reducing visceral adipose tissue in HIV-associated lipodystrophy and is studied for metabolic disorders and aging research[3][4].

  • Standard daily dose: 2 mg (2000 mcg) once daily subcutaneously (FDA-approved protocol).
  • Week 1 Titration: Start with 1 mg (1000 mcg) daily to assess tolerability before advancing to 2 mg.
  • Frequency: Once daily, preferably in the evening to coincide with nocturnal GH release.
  • Storage: Lyophilized & Reconstituted: refrigerate at 2–8 °C (35.6–46.4 °F).

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing across different vial sizes

5 mg Vial Protocol (2.5 mL = 2.0 mg/mL)

WeekDaily Dose (mg / mcg)Units (per injection) (mL)
Week 11 mg / 1000 mcg50 units (0.50 mL)
Weeks 2–12+2 mg / 2000 mcg100 units (1.00 mL)

Reconstitution: Add 2.5 mL bacteriostatic water per 5 mg vial → 2.0 mg/mL concentration. At this concentration, 1 unit = 0.01 mL = 20 mcg on a U-100 insulin syringe.

Reconstitution Steps

  1. Draw 2.5 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

10 mg Vial Protocol (3.0 mL = ~3.33 mg/mL)

WeekDaily Dose (mg / mcg)Units (per injection) (mL)
Week 11 mg / 1000 mcg30 units (0.30 mL)
Weeks 2–12+2 mg / 2000 mcg60 units (0.60 mL)

Reconstitution: Add 3.0 mL bacteriostatic water per 10 mg vial → ~3.33 mg/mL concentration. At this concentration, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

20 mg Vial Protocol (3.0 mL = ~6.67 mg/mL)

WeekDaily Dose (mg / mcg)Units (per injection) (mL)
Week 11 mg / 1000 mcg15 units (0.15 mL)
Weeks 2–12+2 mg / 2000 mcg30 units (0.30 mL)

Reconstitution: Add 3.0 mL bacteriostatic water per 20 mg vial → ~6.67 mg/mL concentration. At this concentration, 1 unit = 0.01 mL ≈ 66.7 mcg on a U-100 insulin syringe.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–16 week daily protocol at the standard 2 mg dose (after Week 1 titration).

For 5 mg Vials:

  • Peptide Vials (8 weeks): ≈ 23 vials (112 mg total)
  • Peptide Vials (12 weeks): ≈ 34 vials (168 mg total)
  • Peptide Vials (16 weeks): ≈ 45 vials (224 mg total)
  • Bacteriostatic Water (10 mL bottles): Use 2.5 mL per vial

For 10 mg Vials:

  • Peptide Vials (8 weeks): ≈ 11 vials (105 mg total)
  • Peptide Vials (12 weeks): ≈ 17 vials (161 mg total)
  • Peptide Vials (16 weeks): ≈ 22 vials (217 mg total)
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial

For 20 mg Vials:

  • Peptide Vials (8 weeks): ≈ 6 vials (105 mg total)
  • Peptide Vials (12 weeks): ≈ 9 vials (161 mg total)
  • Peptide Vials (16 weeks): ≈ 11 vials (217 mg total)
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial

Common Supplies for All Protocols:

  • Insulin Syringes (U-100, 1 mL capacity): Per week: 7 syringes (1/day) → 8 weeks: 56 syringes, 12 weeks: 84 syringes, 16 weeks: 112 syringes
  • Alcohol Swabs: Per week: 14 swabs (2/day) → 8 weeks: 112 swabs, 12 weeks: 168 swabs, 16 weeks: 224 swabs

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Protocol Overview

Concise summary of the FDA-approved once-daily regimen.

  • Goal: Reduce visceral adipose tissue and improve lipid profiles through sustained GH/IGF-1 elevation[3][4].
  • Schedule: Daily subcutaneous injections for 12–26 weeks (extendable to 52 weeks with medical supervision)[3].
  • Dose: 2 mg (2000 mcg) daily after Week 1 titration.
  • Reconstitution: Varies by vial size for accurate measurement.
  • Storage: Lyophilized refrigerated; reconstituted refrigerated; avoid freeze-thaw.

Dosing Protocol

FDA-approved daily dosing approach with tolerability titration.

  • Week 1: 1 mg (1000 mcg) once daily to assess tolerability.
  • Weeks 2+: 2 mg (2000 mcg) once daily (standard FDA-approved dose)[7][8].
  • Frequency: Once per day (subcutaneous), preferably in the evening.
  • Cycle Length: 12–26 weeks; clinical trials support up to 52 weeks with monitoring[3].
  • Timing: Evening administration recommended; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality and efficacy.

  • Lyophilized: Store at 2–8 °C (35.6–46.4 °F); newer formulations (Egrifta SV) stable at 20–25 °C (68–77 °F) before reconstitution[1].
  • Reconstituted (with bacteriostatic water): Refrigerate at 2–8 °C (35.6–46.4 °F)[1].
  • Reconstituted (with sterile water): Use immediately; discard any unused portion[1].
  • Do not freeze reconstituted solution; avoid repeated freeze-thaw cycles.

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes for each injection; dispose in a sharps container[10].
  • Rotate injection sites (abdomen at least 2 inches from navel, thighs, upper arms) to reduce local irritation[6][10].
  • Inject slowly; wait a few seconds before withdrawing the needle.
  • Monitor IGF-1 levels periodically due to potent GH stimulation; observe blood glucose in diabetic patients[9].
  • Document daily dose and site rotation to maintain consistency.

How This Works

Tesamorelin mimics natural human GHRH by binding to pituitary GHRH receptors, triggering pulsatile growth hormone secretion and consequent IGF-1 elevation[2]. This cascade promotes lipolysis (fat breakdown), protein synthesis, and favorable metabolic shifts. In HIV-associated lipodystrophy, daily tesamorelin significantly reduces visceral adipose tissue and improves lipid profiles over 6–12 months[3][4]. Research also explores tesamorelin's potential to reduce liver fat in NAFLD patients and enhance cognitive function in older adults by restoring age-related GH/IGF-1 declines[4].

Potential Benefits & Side Effects

Observations from clinical trials and FDA-approved use.

Potential Benefits:

  • Significant reduction in visceral adipose tissue (measurable after 3–6 months)[3].
  • Improved lipid profiles and potential liver fat reduction in NAFLD[4].
  • Enhanced cognitive function in older adults (research ongoing)[4].
  • Well-tolerated with maintained benefits during continuous use up to 52 weeks[3].

Common Side Effects:

  • Injection-site reactions: Mild redness, itching, pain, or bruising at injection area[9].
  • Musculoskeletal symptoms: Joint pain (arthralgia), muscle aches, peripheral edema (mild swelling)[9].
  • Carpal tunnel symptoms: Occasional tingling or numbness in extremities (dose-dependent, reversible).
  • Metabolic monitoring: IGF-1 elevation requires monitoring; small increases in HbA1c observed in some patients[9].

Contraindications:

  • Active malignancies (tesamorelin may accelerate growth of latent tumors)[9].
  • Pregnancy (may harm fetus)[9].
  • Known hypersensitivity to tesamorelin or mannitol[9].

Lifestyle Factors

Complementary strategies for optimal outcomes.

  • Combine with a balanced, protein-forward diet to support GH/IGF-1 anabolic effects.
  • Integrate resistance training and aerobic activity to maximize fat loss and metabolic benefits.
  • Prioritize 7–9 hours of quality sleep to optimize natural GH pulsatility.
  • Manage stress through mindfulness or relaxation techniques to support adherence and recovery.

Injection Technique

Subcutaneous injection best practices from clinical guidelines[10].

  • Clean the vial stopper and skin with alcohol swabs; allow to air-dry completely.
  • Pinch a skinfold at the injection site (abdomen preferred, at least 2 inches from navel)[6].
  • Insert the needle at 90° (if adequate subcutaneous fat) or 45° (if lean)[10].
  • Release the pinch, then inject slowly; wait 2–3 seconds before withdrawing.
  • Rotate injection sites systematically (left/right abdomen, thighs, upper arms) to prevent lipohypertrophy[6].
  • Dispose of used syringes immediately in a puncture-proof sharps container[10].

Recommended Source

We recommend Legion Peptides for high-purity Tesamorelin (5 mg, 10 mg & 20 mg).

Why Legion Peptides?

  • High-purity, third-party-tested lots with batch COAs (≥99% purity).
  • Consistent, ISO-aligned handling and documentation.
  • Reliable fulfillment to maintain cold-chain integrity.
  • Dedicated customer support for research applications.

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. Tesamorelin is a prescription medication (FDA-approved as Egrifta®) for HIV-related lipodystrophy. Any off-label research use should comply with applicable laws and be conducted under appropriate supervision. This product is provided for laboratory research purposes only and is not intended for human or veterinary use. Consult a qualified medical professional before considering any therapeutic use of tesamorelin.

References

  • Tesamorelin – LiverTox: Clinical and Research Information on Drug-Induced Liver Injury — National Institutes of Health, NIDDK (2018)
  • Tesamorelin (Subcutaneous route) – Drug Information — Mayo Clinic / IBM Merative (2025)
  • Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two phase 3 trials — J. Clin. Endocrinol. Metab. (2010)
  • Safety and metabolic effects of tesamorelin in patients with type 2 diabetes: A randomized, placebo-controlled trial — PLoS ONE (2017)
  • Tesamorelin can improve cognitive function (Research Highlight) — Nature Reviews Endocrinology (2012)
  • Tesamorelin Injection – MedlinePlus Drug Information — MedlinePlus (U.S. National Library of Medicine) (2025)
  • EGRIFTA SV (tesamorelin) – Full Prescribing Information — Theratechnologies, Inc. (FDA Label) (2024)
  • Tesamorelin: Uses, Dosage, Side Effects, Warnings — Drugs.com (AHFS Monograph & Patient Info) (2025)
  • Tesamorelin – LiverTox (Safety Profile) — NIH NIDDK LiverTox Database (2018)
  • Administration of Parenteral Medications – Nursing Skills (Open RN Textbook) — Open RN, Chippewa Valley Technical College (2023)

Research Resources

📘 Research Overview 🧪 Dosage Calculator 🔬 Muscle Growth Performance

Reviews

Natalie K
Natalie KSan Diego
Great for learning more about hunger and satiety signals.
Rajiv S
Rajiv SNewark
Easy to use and helped us get some clear results.
Fatimah L
Fatimah LBoston
Fast delivery and solid packaging. No issues with mixing.
Chris W
Chris WAustin
Worked perfectly for our research on appetite regulation.
Jenny T
Jenny TRaleigh
The stability was great, even after a few days of storage.
Ali R
Ali RPhoenix
Happy with the purchase—smooth and dependable.
Kiara D
Kiara DDenver
Support team was helpful and product quality was excellent.
Oscar B
Oscar BTampa
Exactly what I needed for weight regulation pathway exploration.
Maya J
Maya JColumbus
Easy to handle and very clean—great experience
Noah E
Noah ENashville
Everything arrived cold and intact. Very impressed.
Rania A
Rania ASan Antonio
Came with everything labeled and ready. Worked well.
Kevin F
Kevin FCharlotte
Fast and reliable. Perfect for our satiety hormone study.
Amina Z
Amina ZOrlando
Good clarity and consistent quality. Will order again.
Lucas H
Lucas HCincinnati
The results matched what we hoped for. Good value.
Beatriz S
Beatriz SRichmond
Excellent option for early-stage weight research.

Related Products

BPC-157 / TB-500

Price range: $68.00 through $102.00

Select size This product has multiple variants. The options may be chosen on the product page

MOTS-c

Price range: $33.99 through $77.99

Select size This product has multiple variants. The options may be chosen on the product page

GHK-Cu

Price range: $23.50 through $44.99

Select size This product has multiple variants. The options may be chosen on the product page

Retatrutide

Price range: $34.99 through $189.99

Select size This product has multiple variants. The options may be chosen on the product page

GLP-2 T

Price range: $44.99 through $199.99

Select size This product has multiple variants. The options may be chosen on the product page

Semaglutide

Price range: $39.99 through $149.99

Select size This product has multiple variants. The options may be chosen on the product page
Chat with us
Secure paymentsVISAAMERICANEXPRESSDISCOVERSecure encrypted checkout